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ABSTRACT
The role of Ribonuclease H1 (RNase H1) during
primer removal and ligation at the mitochondrial ori-
gin of light-strand DNA synthesis (OriL) is a key, yet
poorly understood, step in mitochondrial DNA main-
tenance. Here, we reconstitute the replication cy-
cle of L-strand synthesis in vitro using recombinant
mitochondrial proteins and model OriL substrates.
The process begins with initiation of DNA replication
at OriL and ends with primer removal and ligation.
We find that RNase H1 partially removes the primer,
leaving behind the last one to three ribonucleotides.
These 5′-end ribonucleotides disturb ligation, a con-
clusion which is supported by analysis of RNase H1-
deficient patient cells. A second nuclease is therefore
required to remove the last ribonucleotides and we
demonstrate that Flap endonuclease 1 (FEN1) can ex-
ecute this function in vitro. Removal of RNA primers
at OriL thus depends on a two-nuclease model, which
in addition to RNase H1 requires FEN1 or a FEN1-like
activity. These findings define the role of RNase H1
at OriL and help to explain the pathogenic conse-
quences of disease causing mutations in RNase H1.
INTRODUCTION
Humanmitochondrial DNA (mtDNA) is a 16.5 kb double-
stranded circular molecule. The two strands can be sepa-
rated by CsCl2 gradient density centrifugation and are re-
ferred to as the heavy (H) and light (L) strands accord-
ingly (1,2). The genome encodes thirteen essential subunits
of the oxidative phosphorylation system as well as the 2
rRNAs and 22 tRNAs required for their translation. All
other proteins acting in mitochondria are nuclear-encoded
including mtDNA replication factors such as mitochon-
drial DNA polymerase (POL ), the DNA helicase (TWIN-
KLE), and mitochondrial single-stranded DNA-binding
protein (mtSSB).
MtDNA replication is initiated from two different ori-
gins of replication, OriH and OriL, one for each strand.
The process is first initiated from OriH and proceeds uni-
directionally to produce the nascent H-strand (1,3,4).When
the replication machinery has synthesized about two-thirds
of the genome, it passes OriL. When exposed in its single-
stranded conformation, OriL becomes available for the mi-
tochondrial RNA polymerase (POLRMT), which initiates
the synthesis of short RNA primers (5,6). These primers are
used by POL to initiate DNA synthesis in the opposite di-
rection. Once initiated, bothH-strand and L-strand synthe-
sis proceed continuously until two new daughter molecules
are formed.
The RNA primers present at the 5′-ends of the nascent
strands must be removed by nucleases and replaced by
DNA (7–9). A number of nucleases implicated in nuclear
primer removal also have mitochondrial isoforms (RNase
H1, DNA2 and FEN1) (10–14) and mutations in two of
these, RNase H1 and DNA2, are associated with mtDNA
defects and human disease (15,16). Mitochondria also con-
tain a DNA-specific nuclease termedMGME1, which lacks
a nuclear isoform and has been implicated in the process-
ing of 5′-DNA flaps formed by POL -driven strand dis-
placement of DNA ends near OriH. However, MGME1
cannot process RNA flaps (17). The nicks remaining after
primer removal are ligated by DNA ligase III (18). In vitro
analysis of the mitochondrial replication machinery has
demonstrated that failure to remove ribonucleotides from
mtDNA may impair ligation and DNA synthesis, causing
DNA nicks and gaps (19–21). During subsequent replica-
tion cycles, these lesions can cause double-strand mtDNA
breaks and deletions (18,22).
Studies using conditional Rnaseh1 knockout mouse em-
bryonic fibroblasts have demonstrated that loss of RNase
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H1 leads to primer retention at both OriH and OriL (23).
RNase H1 cleaves RNA in RNA-DNA hybrids to generate
free 3′-OH and 5′-phosphate groups (24,25). The enzyme
requires substrates containing at least four ribonucleotides
to be active (24,25). In vitro analysis on primer substrates
has demonstrated that RNaseH1 cuts only between ribonu-
cleotides, leaving at least 2 ribonucleotides attached to the
5′-end of the DNA (26). How and if these residual RNA
residues are removed in mitochondria is not known.
Recently, RNase H1 mutations associated with mtDNA
replication defects were identified in patients with mi-
tochondrial encephalomyopathy (16). In vitro, the mu-
tant proteins V142I, A185V, and R157* (R changed to a
stop codon) have reduced activity on RNA-DNA hybrids.
Analysis of patient samples showed lower mtDNA levels
and increased replication stalling. However, whether RNA
primers were retained at the origins was not determined.
Here, we have addressed the mechanisms of primer re-
moval at OriL. Our findings support the idea that RNase
H1 plays an essential role in this process, but also reveal the
requirement for a second nuclease to complete primer re-
moval and ligation of mtDNA. Our data demonstrate that
FEN1 or an enzyme with FEN1-like activity is required for
the last step of L-strand maturation before ligation as well
as helping to explain the pathogenic consequences of dis-
ease causing mutations in RNase H1.
MATERIALS AND METHODS
Cloning and protein purification
The coding sequence of human RNase H1 carrying a C-
terminal 6 × His-tag without the predicted mitochondrial
targeting sequence (residues 1–26) was cloned into a pBac-
PAK9 vector (Clontech). The mutant RNase H1 versions
V142I and A185V were generated by site-directed mutage-
nesis (Agilent Technologies). Recombinant wild type and
mutant human RNase H1 were expressed in Sf9 insect cells
as previously described (22).
The proteins were purified over HIS-Select Nickel Affin-
ity Gel (Sigma-Aldrich) pre-equilibrated with 10 mM imi-
dazole in buffer A (25mMTris–HCl pH 7.5, 400mMNaCl,
10% glycerol, 10 mM -mercaptoethanol, and 1× protease
inhibitors), followed by elution with 250 mM imidazole in
buffer A. The proteins were subsequently purified over Hi-
Trap Heparin (GE Healthcare) followed by HiTrap SP (GE
Healthcare). The HiTrap columns were equilibrated in 0.2
M NaCl purification buffer (25 mM NaHPO4 pH 7.1, 10%
glycerol, 1 mM DTT and 1× protease inhibitors), and the
proteins were eluted in a 20-ml salt gradient (0.2–1.2 M
NaCl in purification buffer). Recombinant human DNA2
withN-terminal 6×His andC-terminal FLAG-affinity tags
was expressed and purified from Sf9 insect cells as previ-
ously described (27). Recombinant MGME1, POLRMT,
POLA/B (note we use exonuclease competent POLA),
DNA ligase III, mtSSB and FEN1 proteins were purified
as previously described (17,22,28–30). Subsequent dilutions
were performed in 25mMTris–HCl pH 7.5, 1mMDTT, 0.1
mg/ml bovine serum albumin (BSA), 100 mM NaCl and
10% glycerol (17).
Oligonucleotides
All oligonucleotides were PAGE purified where necessary
(Eurofins MWGOperon). With the exception of the primer
extension oligonucleotide, all oligonucleotides used in this
study had anOriL specific sequence (see Supplementary Ta-
ble S1 for sequence details). Oligonucleotides were radiola-
belled on the 5′ or 3′-end. For 5′-end labelling, T4 polynu-
cleotide kinase (NEB) and [ -32P] ATP were used. For 3′-
end labelling, a 51 nt long 26RNA:25DNA oligonucleotide
was radiolabelled to generate a 52 nt long 26RNA:26DNA
oligonucleotide by one of two methods: 3′-end labelling us-
ing Klenow fragment fill-in and [-32P] dCTP; or, 3′-end la-
belling using terminal transferase (NEB) and [-32P] dCTP,
followed by 3′ overhang removal using T4DNApolymerase
(NEB). For assays using a minicircle substrate, a 120 nt
template oligonucleotide was circularized using CircLigase
II ssDNA ligase (Epicenter). Labelling occurred by the in-
corporation of [-32P] dCTP during the experimental reac-
tions. Further details about substrates are given in the assay-
specific sections below.
Nuclease activity assay
Nuclease activity reactions were performed on an 80 nt
DNA template annealed to a 3′ end labelled 52 nt chimeric
oligonucleotide that contained 26 ribonucleotides followed
by 26 deoxyribonucleotides (26RNA:26DNA, Figure 1A).
The reactions (20 l) contained 1 × RNase H buffer (50
mM Tris–HCl pH 8.0, 75 mM KCl, 3 mM MgCl2 and 10
mM DTT), 20 fmol substrate, and increasing concentra-
tions of RNase H1 wild type or mutants (10–300 fmol).
The reactions were incubated at 37◦C for 60 min and then
stopped by the addition of 5 l stop buffer (10 mM Tris–
HCl pH 8.0, 0.2 M NaCl, 1 mM EDTA, 660 g/ml glyco-
gen [Roche], and 100 g/ml proteinase K [Ambion]) fol-
lowed by incubation at 42◦C for 45 min. The samples were
recovered by ethanol precipitation in the presence of 0.5-
volume ammonium acetate (7.5 M) and dissolved in 10 l
of TE buffer. The samples were then treated with 300 mM
KCl or KOH for 2 h at 55◦C and stopped with 2× stop
buffer (formamide with 10 mM EDTA, 0.025% bromophe-
nol blue and 0.025% xylene cyanol).
For determination of product lengths, 10 fmol
of low molecular DNA weight marker 10–100 nt
(Affymetrix/USB) was radiolabelled with T4 PNK (NEB)
at the 5′ end. To map the activity of RNase H1, a ladder
was made of four 3′-end labelled oligonucleotides with
the same sequence as the 26RNA:26DNA downstream
oligonucleotide, but with 0, 1, 2 or 3 ribonucleotides at the
5′-end.
Denaturing electrophoresis of samples was performed
in 7 M urea/10% polyacrylamide high-resolution sequenc-
ing gels, and the products were visualized by autoradiog-
raphy (Fujifilm) or phosphorimaging. All radiolabelled nu-
cleic acids migrated as single-stranded species. Quantifica-
tion of endonuclease activity was performed using the pro-
gram Multi Gauge (Fuji film) with images generated from
a Phosphorimager. The intensity of substrate bands was
measured and compared with the negative control substrate
band. P-values were calculated using an unpaired Student’s
t-test in GraphPad prism. All experiments were performed
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Figure 1. Disease causingmutations inRNaseH1 impair primer processing. (A) The cleavage pattern of wild typeRNaseH1. The 3′-labelledOriL substrate
is shown at the top (RNA- red, DNA- black). KOH removes all RNA. 3′-labelled chimeric oligonucleotides were used as a size marker. Wild type RNase
H1 efficiently cleaved the RNA near the RNA-DNA junction, but did not cleave the last 1–3 ribonucleotides. (B) The cleavage patterns of wild type and
mutant RNase H1. The V142I mutant had decreased activity (∼35-40 nt products); the A185V mutant was inactive. The size marker (M) is labelled at the
5′ end. (C) The endonuclease activity in B was quantified from phosphorimager obtained images: the amount of non-hydrolysed substrate was measured
against the negative control input bands (lanes 1, 6 and 11). Mean values ± s.e.m., n = 3, P ≤ 1 × 10−3 (Student’s unpaired t-test). (D) Thermofluor
stability assay shows that the V142I and A185V mutations severely destabilise RNase H1. A185V shifted the Tm by 23.36◦C; V142I had severe folding
defects, with a near-unfolded state under native conditions. (E) The potential structural/functional consequences of the V142I and A185V mutations were
assessed by looking at the crystal structure of wild type RNase H1. Catalytically important residues shown in magenta alongside Ala185 and Val142 (PDB
ID: 2QK9). Both residues are located near the active site. (F) Ala185 is adjacent to the catalytically essential Glu186, which coordinates a catalytic Mg2+
ion and forms part of a hydrophobic pocket that mediates the stabilising interactions in the active site region. The A185V mutation causes a steric clash
in this pocket. (G) Val142 stabilises the hydrophobic interface between helix 1 and sheet 1. This interface is critical for proper alignment of Asp145 and
Glu186 in catalysis which is likely disturbed in the V142I variant.
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at least three times and representative figures for each ex-
periment are shown.
Thermofluor stability assay
The fluorescent dye Sypro Orange (Invitrogen; ex = 490
nm, em = 570 nm) was used to monitor the temperature-
induced unfolding of wild type and mutant RNase H1. As
the protein unfolds at high temperatures, the dye binds to
exposed hydrophobic residues. This enables monitoring of
the unfolding pathway and subsequent determination of rel-
ative thermal stability (melting temperature: Tm).Wild type
and mutant proteins were set up in 96-well PCR plates at
a final concentration of 1.6 M protein and 5× dye in as-
say buffer (50 mM Tris–HCl pH 7.8, 10 mM DTT, 50 mM
MgCl2 and 5 mM ATP). Differential scanning fluorimetry
was performed in aC1000 Thermal Cycler using the CFX96
real-time software (BioRad). Scans were recorded using the
HEX emission filter (560–580 nm) between 4 and 95◦C in
0.5◦C increments with a 5 s equilibration time. The melting
temperature, Tm was determined from the first derivative of
a plot of fluorescence intensity versus temperature (31). The
standard error was calculated from three independent mea-
surements.
Ligation assay
A nicked 80 nt substrate was created by annealing the 80 nt
template strand to a 50 nt upstream oligonucleotide and a
30 nt 5′-end labelled downstream oligonucleotide contain-
ing a stretch of ribonucleotides of varying length at the 5′-
end (Figure 3C). The reactions (20 l) contained 1× lig-
ation buffer (50 mM Tris–HCl pH 7.5, 10 mM MgCl2, 1
mM ATP and 10 mM DTT), 20 fmol nicked substrate and
increasing concentrations of T4 DNA ligase (NEB) (1–8 U)
or DNA ligase III (80-320 fmol). The reactions were incu-
bated at 37◦C for 60 min and then stopped with 2× stop
buffer. Samples were analyzed by denaturing electrophore-
sis in 7 M urea/10% polyacrylamide gels and visualization
was performed as described above (nuclease activity assay).
Coupled nuclease gap-filling and ligation assay
Coupled nuclease gap-filling and ligation assays were per-
formed on an 80 nt substrate that contained an 8 nt gap
flanked by a 20 nt upstreamDNAoligonucleotide and 52 nt
downstream chimeric (26 RNA:26 DNA) oligonucleotide
(Figure 4A). Either the upstream oligonucleotide was 5′-
labelled (Figures 3A, 4A, 5A) or the downstream oligonu-
cleotide was 3′-end labelled (Figures 4C, 5C) as described
above (oligonucleotides).
The reactions (25 l) contained 1 × reaction buffer (10
mM Tris–HCl pH 7.5, 10 mM DTT, 0.1 mg/ml BSA, 10
mM MgCl2, 1 mM ATP and 100 M dNTPs), 20 fmol
substrate, 150 fmol wild type or mutant RNase H1, 300
fmol POLA and 600 fmol POLB (calculated as a dimer).
Where indicated, the reactions contained different concen-
trations of FEN1, DNA2 or MGME1. The reactions were
incubated at 37◦C for 60 min.When gap-filling was coupled
to ligation, 1 U of T4 DNA ligase or 300 fmol DNA lig-
ase III was added after 20 min of incubation at 37◦C. The
reactions were then incubated for a further 1 h. The reac-
tions were stopped with 2× stop buffer. The same 10–100 nt
size marker as in the nuclease assay was used. To precisely
determine the size of POL -extended products, 5′-labelled
upstream oligonucleotides of different lengths were used as
additional size markers (Supplementary Figure S1B). De-
naturing electrophoresis and visualization of samples was
performed as described for the nuclease activity assay.
Primer extension
Genomic DNA was isolated from control and patient fi-
broblasts with compound heterozygous mutations (V142I
and V185A) in the RNASEH1 gene. Cell pellets were resus-
pended in lysis buffer (10mM Tris–HCl pH 8.0, 100mM
NaCl, 25mM EDTA and 0.5% SDS) and 100 g/ml pro-
teinase K, and incubated for 1 h at 42 ◦C. Total DNA was
extracted using phenol-chloroform extraction and ethanol
precipitation. A 5′-end labelled primer (Supplementary Ta-
ble S1) was annealed to 1g of the total DNAand extended
with Taq polymerase for 20 cycles of 95◦C 30 s, 58◦C 30
s and 72◦C45 s, with a final 5min incubation at 72◦C.Before
primer extension, someDNA samples were treated withEs-
cherichia coli RNase H (NEB; 5U per 1 g DNA) for 1 h
at 37 ◦C. Primer extension reactions were separated using
denaturing 4.5% polyacrylamide sequencing gels. The gels
were dried and scanned using a Phosphorimager or exposed
to X-ray film (Fuji).
Coupled primer formation and primer removal assay on a
minicircle template
A circular 120 nt oligonucleotide with an OriL specific se-
quence (Supplementary Table S1) was used as a template
for the coupled primer formation and primer removal as-
say. The reactions (25 l) contained 1 × reaction buffer
(25 mM Tris–HCl pH 7.5, 10 mM DTT, 0.1 mg/ml BSA,
10 mM MgCl2, 1 mM ATP, 10 M dNTPs, and 150 M
NTPs [UTP, CTP, and GTP]), 40 fmol template, 150 fmol
wild type or mutant RNase H1, 300 fmol POLA, 600 fmol
POLB (calculated as a dimer), 50 fmol mtSSB (calculated
as a tetramer), 250 fmol POLRMT and, where indicated,
35 fmol FEN1 or 200 fmol MGME1.
The template was labelled by the incorporation of [-
32P] dCTP during the experimental reactions. The reactions
were incubated at 37◦C for 30 min, after which 1 U of T4
DNA ligase or 300 fmol DNA ligase III was added. The
reactions were then incubated at 16◦C for 18 h and then
stopped by addition of 5 l stop buffer (10 mM Tris–HCl
pH 8.0, 0.2 M NaCl, 1 mM EDTA, 660 g/ml glycogen
[Roche] and 100 g/ml proteinase K [Ambion]) followed
by incubation at 42◦C for 45 min. The samples were recov-
ered by ethanol precipitation in the presence of 0.5-volume
ammonium acetate (7.5 M) and then dissolved in 10 l TE
buffer. KOH treatment was carried out using the same pro-
cedure as described for the nuclease assay. A low molecular
weight DNA ladder (NEB) was labelled at the 5′-end and
used as size marker. Denaturing electrophoresis and visual-
ization of samples was performed as described for the nu-
clease activity assay.
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RESULTS
RNase H1 degrades ribonucleotides at OriL
To study the enzymatic activity of mitochondrial RNase
H1 at OriL, we purified wild type RNase H1 in recom-
binant form. We also expressed and purified two mutant
RNase H1 variants associated with human disease, V142I
andA185V. Tomonitor RNaseH1 activities in vitro, we cre-
ated a substrate mimicking an RNA-primed DNA synthe-
sis product formed by initiation at OriL, containing an 80
nt long template strand annealed to a 3′-end labelled 52 nt
long chimeric oligonucleotide with 26 ribonucleotides fol-
lowed by 26 deoxyribonucleotides (26RNA:26DNA;Figure
1A). The RNA stretch was selected to match the previously
mapped RNA primer formed at OriL in vivo (32).
Consistent with a functional role in removal of the primer
at OriL, wild type RNaseH1 efficiently cleaved and reduced
the size of the substrate (Figure 1A, lanes 2–4). In par-
allel, we treated the RNA:DNA strand with KOH, which
chemically hydrolyzes ribonucleotides (Figure 1A, lane 5).
RNase H1 treated samples migrated slower than the KOH
treated samples, demonstrating that RNase H1 did not
process all the ribonucleotides. Comparison of RNase H1
product sizes against an oligonucleotide ladder (Figure 1A,
lanes 6–9) showed that the last 1–3 ribonucleotides at the
RNA:DNA junction are unprocessed by RNase H1.
We also analysed the two disease-causing, mutant forms
of RNase H1, V142I and A185V (Figure 1B, C). The V142I
mutant displayed only weak RNase H1 activity (36% com-
pared to wild type) and it left a longer stretch of unpro-
cessed ribonucleotides to form ∼35–40 nt product bands.
The A185V mutant had no discernible activity (6% com-
pared to wild type), leaving the RNA primer unprocessed.
Disease causing mutations disrupt the conformational stabil-
ity of RNase H1
To better understand the consequences of the V142I and
A185V mutations, we performed thermofluor stability as-
says using the fluorescent dye SYPRO Orange to monitor
the temperature-induced unfolding of wild type andmutant
RNase H1. Both mutations severely destabilized RNase
H1, with A185V shifting the Tm from 47.07◦C to 23.71◦C
(Tm = 23.36◦C) whilst V142I appeared to have severe
folding defects resulting in a near-unfolded state under na-
tive conditions (Figure 1D). This correlates well with the
observed catalytic defects and suggests that the mutations
disrupt the global structure and conformational stability of
RNase H1. Analysis of the modelled mutations shows that
both residues are located in close proximity to the active site
(Figure 1E). The V142I and A185V substitutions both in-
duce a steric clash within the catalytic cavity which likely
induces structural destabilization and improper alignment
of the catalytic residues (Figure 1F, G). Ala185 is situated
adjacent to the catalytically-essential Glu186 which coor-
dinates a catalytic Mg2+ ion (which subsequently stabilises
a water molecule for nucleophilic attack by the 3′ ribose
oxygen). Val142 plays a similar role within a hydrophobic
interface between helix 1 and sheet 1. This interaction
is critical for maintaining proper alignment of Asp145 and
Glu186 for catalysis. A similar set of interactions has been
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Figure 2. RNase H1 mutations A185V and V142I together impair primer
processing at OriL in vivo. PEx analysis of the OriL region (shown in top
panel) in RNase H1 patient fibroblast (PF) and control fibroblast (CF)
DNA. Samples were (+) or were not (–) treated in vitro with E. coliRNase
H before PEx analysis. The sequence (in bold) where RNA-DNA tran-
sitions have been previously mapped (45) is shown to the right. Shorter
products mapping to the known RNA–DNA transitions downstream of
OriL accumulated in the RNase H-treated samples.
shown to mediate distal interactions with a catalytic Mg2+
ion in HIV RT RNase H (33).
RNase H1 mutations impair primer removal at OriL in vivo
We next monitored the effects of mutant RNase H1 on
primer removal in vivo. For this, we used patient fibroblasts
with compound heterozygous mutations V142I and V185A
in the RNASEH1 gene (16). We used a primer extension
(PEx) assay to detect 5′-ends in vivo (Figure 2). A radioac-
tively labeled primer was annealed to total DNA extracted
from fibroblasts approximately 200 nt downstream (5947–
5927 nt) of the poly(T) stretch in theOriL stem-loop (Figure
2, upper panel), followed by extension withTaq polymerase.
PEx in patient fibroblasts identified 5′-ends in the OriL re-
gion, not observed in wild type control fibroblasts (Figure
2, compare lanes 5 and 7). The observed 5′-ends were sensi-
tive to RNaseH treatment, since shorter products mapping
to the known RNA-DNA transitions downstream of OriL
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accumulated in the RNaseH-treated patient samples (Fig-
ure 2, lane 8). Our observation was thus in agreement with
our in vitro findings and we conclude that RNA primers are
retained at OriL in RNase H1 deficient patient cells.
RNase H1 is insufficient for maturation of the nascent L-
strand during DNA synthesis
Our finding that RNase H1 leaves 1–3 unprocessed primer
ribonucleotides implies that these RNase H1-resistant ri-
bonucleotides are either tolerated and ligated into newly
replicated L-strands, or removed by a second nuclease. To
address these possibilities, we investigated if RNase H1 pro-
cessing of primers enabled ligation during activeDNArepli-
cation (Figure 3). Using a gapped OriL template, DNA
synthesis was coupled to primer removal and ligation us-
ing POL , RNase H1 and DNA ligase III (Figure 3A).
We found that POL could initiate from the upstream
oligonucleotide and synthesize across an 8 nt long ssDNA
gap region. When POL reached the 5′-end of the RNA-
containing downstream oligonucleotide it stopped mainly
at nucleotide position 28 (creating a perfect nick) or 29 (cre-
ating a 1 nt flap) (Figure 3B, lane 2). Addition of RNase H1
resulted in removal of the RNA region of the downstream
oligonucleotide and POL could continue DNA synthesis
until it reached the processed 5′-end (Figure 3B, lane 3). The
length (∼53–55 nt) of the extended oligonucleotide primer
was consistent with 1–3 ribonucleotides still being attached
to the downstream oligonucleotide (Supplementary Figure
S1).
We next added DNA ligase III to ligate the newly synthe-
sized DNA to the downstream oligonucleotide to form an
expected product of 80 nt. Interestingly, we observed nearly
no ligated products even at high concentrations of ligase
III, suggesting that the remaining ribonucleotides block ef-
ficient ligation (Figure 3B, lanes 4–6). In support of this
notion, T4 DNA ligase, which can ligate RNA (34), could
readily form a ligated product of 80 nt (Figure 3B, lane 7).
We also tested ligase III activity on a series of nicked sub-
strates where the downstream RNA-DNA oligonucleotide
contained incrementally shorter stretches of RNA residues
on the 5′-end (Figure 3C). In this experimental setup, which
did not contain RNase H1 or POL , we found that the
negative effects of ribonucleotides on DNA ligase III ac-
tivity were less pronounced than in the coupled reactions
shown above. Though≥5 RNA residues at the 5′-end of the
RNA-DNA junction completely abolished ligation, we did
observe ligation with 2 RNA residues. Active DNA replica-
tion and primer processing appear to have made DNA lig-
ase III less prone to ligate oligonucleotides containingRNA
residues at the 5′-end. The heterologous T4DNA ligase was
less sensitive to the presence of ribonucleotides than DNA
ligase III (consistent with the coupled reaction results), and
could ligate products with 5 RNA residues (Figure 3D).
We next extended our analysis to the RNase H1 patient
mutants to see whether they could support ligation in the
context of replicating POL . We focused only on T4 DNA
ligase, since DNA ligase III activity was undetectable even
with wild type RNase H1 as discussed above (Figure 3B).
While wild type RNase H1 together with T4 DNA ligase
produced a ligated product, negligible ligation was seen
with the mutant proteins (Figure 3E). Longer extension
products were formed with the V142I mutant compared to
A185V; this can be explained by V142I being able to remove
some ribonucleotides (Figure 1B, compare lanes 7–9 with
lanes 12–14) and thus making a longer gap for POL to
fill.
A FEN1-like activity together with RNase H1 is needed for
efficient ligation at OriL
Our data indicate that RNase H1-resistant ribonucleotides
would have an adverse effect on mtDNA integrity by block-
ing ligation of the nascent DNA strand, suggesting that mi-
tochondrial primer removal requires an additional nuclease
to remove the final 1–3 ribonucleotides at the 5′-end of the
nascent L-strand. We therefore investigated if other, pre-
viously identified mitochondrial nucleases could comple-
ment RNase H1 during primer removal. We used FEN1,
MGME1 and DNA2 as these nucleases have been shown to
cut flaps and to have mitochondrial localisation (35–37).
Using our coupled gap-filling ligation assay we included
the different nucleases with RNase H1 and asked if they
could remove the remaining ribonucleotides at the RNA-
DNA junction to enable ligation (Figure 4A). A ligated
product was formed after the addition of FEN1, indicat-
ing that FEN1 removed the RNase H1-resistant ribonu-
cleotides (Figure 4B). Conversely, neither MGME1 nor
DNA2 stimulated ligation even at high concentrations (Fig-
ure 4B and Supplementary Figure S2). These findings are
consistent with the reported enzymatic activities of FEN1,
which is a flap-specific nuclease that can cleave short RNA
or DNA flaps. In contrast, MGME1 and DNA2 are DNA
specific nucleases that require longer primer flaps than those
produced by POL strand displacement (35,36).
We next repeated the assay on the same gapped template,
but positioned the radiolabel on the 3′-end of the down-
stream oligonucleotide (Figure 4C), instead of the 5′-end of
the upstream oligonucleotide. With this 3′ label, we could
directly track nuclease and DNA ligation activity, and con-
firm that the observed ligation was not related to POL
strand displacement. In the presence of only nucleases, we
saw that FEN1 hydrolysed the remaining ribonucleotides
left by RNase H1 (Figure 4D, compare lanes 2 and 4). Fur-
thermore, when the assay was done with POL and ligase
III, we only observed ligation when both FEN1 and RNase
H1 were present (Figure 4D, lane 7). In contrast, when the
assay was done with POL and T4 DNA ligase, we ob-
served ligationwithRNaseH1 in the absence of FEN1 (Fig-
ure 4D, lane 8). As a control, we also repeated the experi-
ments with a template containing only DNA (Figure 4D,
lanes 11–14).
We next examined if FEN1 could replace RNase H1 and
execute RNA primer removal alone using the same coupled
gap-filling ligation assay as above. No ligated product was
observed in the presence of FEN1 alone or in combination
with the mutant versions of RNase H1 (V142I or A185V),
showing that FEN1 is unable to compensate for RNase H1
deficiency (Figure 5A, B). A similar finding was observed
using a 3′-end labelled template (Figure 5C, D). Together
our findings indicate that neither FEN1 nor RNase H1 on
their own can support complete primer removal to create a
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Figure 3. RNase H1 processing coupled to POL dependent DNA synthesis does not produce ligatable nicks. (A) Schematic of the coupled nuclease
gap-filling ligation assay performed on a gapped OriL substrate (a). The upstream oligonucleotide was radioactively labelled at the 5′-end. The possible
products are illustrated (b–d). (–) Coupled nuclease gap-filling ligation assay as shown in A. POL filled the gap (lane 2, marked b) and had limited strand
displacement activity (SD). Note though that POL completely displaces the downstream oligonucleotide in a small fraction of templates (80 nt band,
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of the nick in the presence of 80–320 fmol DNA ligase III. DNA ligase III discriminates against nicked substrates that contain increasing stretches of
ribonucleotides. Two, but not five or more ribonucleotides, can be ligated. (D) As in C, except performed with T4 ligase (1–8 U). T4 ligase can ligate five
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or without FEN1 to monitor nuclease activity. RNase H1 cleaved the downstream oligonucleotide leaving 1–3 unprocessed ribonucleotides. FEN1 cleaved
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showed ligation only when both RNase H1 and FEN1 were added. However, T4 DNA ligase could ligate without FEN1. Lanes 12–14 are ligation controls
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the template. During the idling process the 3′-5′ exonuclease activity of POL cleaves off the 3′-end label.
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ligatable 5′-end. Instead, RNase H1 is required to remove
most of the ribonucleotides in the primer, with the remain-
ing ribonucleotides displaced into a short flap by POL ,
which is then cleaved by FEN1.
Reconstitution of primer removal and ligation at POLRMT-
primed OriL
Having established an in vitro assay for primer removal and
ligation, we next extended the system to combine primer
formation and removal at OriL. We designed a small cir-
cular ssDNA template containing the OriL sequence (Fig-
ure 6A, denoted a). After primer formation by POLRMT
(Figure 6A, denoted b), POL will initiate DNA synthe-
sis from the origin. The reaction proceeds to full circle, at
which point the replicating POL encounters the 5′-end of
the primer from which it had once initiated DNA synthe-
sis (Figure 6A, denoted c). To monitor DNA synthesis, we
included [-32P] dCTP in the reactions.
We first investigated if the presence of RNase H1 affected
primer formation by POLRMT at OriL. Using the mini-
circle template, we found that POLRMT and POL could
efficiently initiate DNA synthesis both in the absence and
presence of RNase H1 to produce a ∼120 nt product (Fig-
ure 6A and B, lanes 2–5), demonstrating that RNase H1
activity does not disturb the initiation process, i.e. primer
handover from POLRMT to POL . However, RNase H1
efficiently removed the primer after initiation of DNA syn-
thesis, as revealed by post-replication treatment of products
with KOH (Figure 6 B, lanes 7–10). Replication products
formed in the absence of wild type RNase H1 or with the
RNase H1-deficient mutants were KOH sensitive and re-
sulted in truncated species demonstrating that the primers
were not removed in these reactions (Figure 6A, denoted c,
left panel and Figure 6B, lanes 7, 9, 10). Note, since it is
DNA that is labelled during the synthesis reaction, the in-
tensity of the 120 nt products is weaker if the RNA primer
is not removed (Figure 6B, compare lanes 2, 4 and 5, with
lane 3).
We next used the POLRMT-primed minicircle assay to
investigate the efficiency of primer removal coupled to lig-
ation with ligase III (Figure 6C). Here, primer removal
and ligation are essential to create a closed circular nascent
circle. Confirming our previous experiments, ligation effi-
ciency was poor with RNase H1 alone, even in the pres-
ence of POLRMT (Figure 6D, lane 5). When FEN1 was
also added, we observed efficient ligation and the forma-
tion of closed circular replication products (Figure 6D, lane
8). Also, addition of FEN1 could partially rescue ligation in
combination with the mutant V142I RNase H1 (Figure 6D,
lane 9). In contrast, addition of MGME1 failed to support
efficient ligation (Figure 6D, lane 11), as expected from our
previous data. The requirement for RNase H1 and FEN1
to generate closed circular products was also observed us-
ing an oligonucleotide-primed minicircle template (Supple-
mentary Figure S3).
We next asked whether the ligated closed circular prod-
ucts contained any retained primer ribonucleotides. For
this, we performed the POLRMT-primed minicircle assay
with T4 DNA ligase, and then tested whether the closed cir-
cular products could be subsequently converted to nicked
circles by KOH treatment (Supplementary Figure S4A).We
found that the ligated products formed in the presence of
RNase H1 were KOH-sensitive, whereas ligated products
formed in the presence of both RNase H1 and FEN1 were
resistant to KOH (Supplementary Figure S4B). This shows
that ribonucleotides are completely removed by RNase H1
and FEN1 prior to ligation.
DISCUSSION
In an Rnaseh1 knock-out mouse model, a portion of
mtDNA molecules contains long stretches of ribonu-
cleotides at the origins of replication (23). This observa-
tion raised the idea that RNase H1 is involved in mtDNA
primer processing. However, it remained unclear if RNase
H1 alone was sufficient for this process or if additional fac-
tors were required. In this report, we have reconstituted
primer formation, primer removal and ligation at OriL in
vitro. In parallel, we have analysed primer processing in
fibroblasts derived from patients with mutant versions of
RNase H1. Our findings suggest that RNase H1 is essential
for primer removal, but that an additional nuclease activity
is required to create ligatable ends. If the ribonucleotides
are not completely removed it will lead to a nick in the
DNA that will become a double-stranded break during the
next round of replication. It is worth noting that although
mtDNA is known to contain a small number of ribonu-
cleotides (38,39), these are believed to originate from mis-
incorporation by POL during DNA synthesis and are not
formed by incomplete primer removal (40).
As demonstrated here, during processing of primers used
for replication initiation at OriL, RNase H1 leaves 1–3 un-
processed ribonucleotides attached to the nascent DNA
strand. These RNA residues block DNA ligase III activ-
ity and must therefore be removed prior to ligation. FEN1
has the ability to cleave short RNA flaps (41) and in vitro
analyses presented here suggest that FEN1 could be the en-
zyme that removes the ribonucleotides left behind byRNase
H1. The necessary flaps are most likely formed by POL ,
which is known to continue polymerizing a few nucleotides
into duplex regions, creating short 5′-flaps in the displaced
strand. These short, RNA-containing flaps can then be rec-
ognized and cleaved by FEN1 (see model in Figure 7). The
mechanism is similar to Okazaki fragment maturation in
nuclearDNA replication (36). As demonstrated here, FEN1
andRNaseH1 are non-redundant and both are required for
correct processing. However, FEN1 can partially rescue lig-
ation in combination with the RNase H1 mutant (V142I)
which has reduced RNA processing activity. It should be
noted that the complete loss of either RNase H1 or FEN1
causes embryonic lethality in mice (42,43).
Even if we here demonstrate that FEN1 can assist RNase
H1 to produce ligatable ends at OriL in vitro, we have so
far not obtained conclusive evidence for FEN1 playing this
role in vivo. We are therefore open to the possibility that a
second, FEN1-like nuclease can assist in primer processing
in mammalian mitochondria. One reason for this conser-
vative interpretation of our data is that the mitochondrial
localization of FEN1 has been questioned. Some studies
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Figure 6. Reconstitution of primer formation, removal, and ligation of the nascent L-strand. (A) Schematic of the minicircle replication assay in B, using
a circular oligonucleotide (120 nt) with OriL-specific sequence. Although shown as consecutive steps, all proteins were added simultaneously. The template
was labelled by the incorporation of [-32P] dCTP during reactions. After inactivation, samples were treated with KOH to hydrolyze RNA. (B) RNase
H1 cleaves POLRMT-generated primers after replication is initiated on the minicircle. Lane 1 and lane 6 did not contain POLRMT as a negative control
in primer formation, and no labelled product was observed. Short 20–50 nt products represent unutilized primers. After overnight incubation, reactions
were stopped and treated with 300 mM KCl as control (lanes 1–5) or KOH (lanes 6–10). Only reactions with wild type RNase H1 were unaffected by
KOH treatment (lane 8, full-length band), indicating RNase H1 had processed the POLRMT-delivered primer. Retained RNA due to incomplete primer
removal was degraded by KOH, leading to truncated products (lanes 7, 9, 10). It is worth noting that POLRMT seems to be able to incorporate low levels
of dCTP, as has previously been shown for T7 RNA polymerase (46), explaining the labeling of the short primers in lanes 2, 4 and 5. (C) Schematic of
the minicircle replication assay coupled to ligation used in D. The template was incubated with POL , POLRMT, and RNase H1 or mutants and, where
indicated, FEN1 orMGME1 for 30 min at 37◦C. 300 fmol DNA ligase III was then added (lanes 5–14), and the samples were incubated at 16◦C overnight.
(D) Efficient ligation (marked closed circle) of minicircle replication products was observed in the presence of FEN1 and wild type RNase H1 (lane 8).
Moderate ligation was observed with FEN1 and the V142A RNase H1 mutant (lane 9). MGME1 did not affect ligation efficiency (lanes 11–13). Reactions
were performed as shown in C.
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Figure 7. Model for primer processing at OriL. RNase H1 cuts the RNA
primer but leaves 1–3 ribonucleotides at the RNA:DNA junction. POL
fills the gap and continues to synthesize a few nucleotides into the duplex
region, creating a short 5′-flap containing the RNA. FEN1 or a FEN1-
like activity cleaves the short RNA flaps and DNA ligase III can ligate the
DNA.
have argued against the existence of a mitochondrial iso-
form and noted the absence of a classical mitochondrial
targeting sequence (11–13,44). Furthermore, even if a spe-
cific mitochondrial isoform of FEN1 has been identified,
denoted FEN-MIT, this isoform lacks parts of the nucle-
ase domain and is therefore not expected to have the enzy-
matic activity necessary for primer processing (38). Finally,
we have not been able to observe effects of FEN1 depletion
on OriL-ligation in vivo (data not shown). Together, these
observations argue for the possibility that a yet to be de-
fined nuclease may perform the role as the second nuclease
needed for primer processing at OriL in vivo. Despite this,
our data clearly demonstrate that RNase H1 is unable to
adequately process primers on its own and that FEN1, or
a FEN1-like activity, is clearly needed for primer removal
at OriL. In future work, we will use genetic tools to dissect
the in vivo function of FEN1 in mitochondria. We will also
attempt to purify a second nuclease frommitochondrial ex-
tracts to conclusively determine its identity.
The ability of DNA ligase III to ligate a nick next to a
stretch of downstream ribonucleotides may be influenced
by on-going DNA replication. As observed here, ligation
is not blocked by 2 ribonucleotides in a nicked substrate
(Figure 3C). In contrast, ligation is efficiently blocked by
1–3 ribonucleotides when coupled to DNA synthesis and
primer processing (Figure 3B). This discrepancy may re-
flect a mechanism whereby ligation is blocked until the last
1–3 RNase H1-resistant ribonucleotides are removed, thus
preventing the incorporation of short RNA stretches into
daughter molecules. This mechanism could be important
given that RNase H1 is the only mitochondrial RNase H
and cannot cleave RNA tracts shorter than four nucleotides
(10).
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